Carbon footprint of direct oral anticoagulants in atrial fibrillation and venous thromboembolism

L. Chery; Zahra Hassani; L Durand; D. Boisseau; Victorien Monguillon; David Grimaldi; Sébastien Taillemite; B. De Sainte Marie; Nicolas Gendron

doi:10.3324/haematol.2025.300204

December 11, 2025HaematologicaOpen Access

Carbon footprint of direct oral anticoagulants in atrial fibrillation and venous thromboembolism

View Full Paper

Ask AI

Bookmark

Share

Key Points

To evaluate the carbon footprint associated with direct oral anticoagulants in atrial fibrillation and venous thromboembolism.
Assess carbon emissions of direct oral anticoagulants
Analyze usage in atrial fibrillation and venous thromboembolism cases
Identified significant carbon footprint linked to direct oral anticoagulants
Highlights the environmental implications of anticoagulant therapy

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Analysis reveals carbon footprint of direct oral anticoagulants in atrial fibrillation and venous thromboembolism, suggesting environmental impacts need consideration.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Chery et al. (2025) studied this question.

synapsesocial.com/papers/694019342d562116f28f6d9f https://doi.org/10.3324/haematol.2025.300204

View Full Paper

Ask AI

Bookmark

Share

Carbon footprint of direct oral anticoagulants in atrial fibrillation and venous thromboembolism

Key Points

No abstract yet

Ask about this paper

Implication

Discussion

Cite This Study

Carbon footprint of direct oral anticoagulants in atrial fibrillation and venous thromboembolism

Key Points

No abstract yet

Ask about this paper

Implication

Discussion

Cite This Study

Keep reading

Keep reading